Formulation Chemistry Scientist – Preclinical Drug Delivery

Eurofins; Hartford; On-site; GBP 33,000 - 37,000; Full time

Benefits offered by this job

Medical coverage

Dental coverage

Vision coverage

401(k) match

Paid vacation

Life insurance

Disability insurance

Job summary

Eurofins PSS seeks a highly motivated scientist to support the client's Early Formulation Science and Drug Delivery group on a client site in Cambridge, MA, with daily onsite presence five days a week.

This role will develop stage-appropriate traditional and enabled formulations for preclinical studies, conduct basic in vitro experiments and simple data interpretation to assess bio-performance and stability risks in small molecule drug candidates.

Qualifications

• MS with 2-4 years of experience, or BS with 3-6 years in Chemistry, Chemical Engineering, Physical Chemistry, Physics, Pharmaceutics, or Pharmaceutical Sciences.
• Experience in pharmaceutical R&D supporting drug discovery or early development programs.
• Hands-on experience with small molecule drug candidates and physicochemical characterization.

Responsibilities

• Predict and evaluate physicochemical properties of small molecule candidates.
• Develop and evaluate formulations for preclinical studies (oral, subcutaneous, IV).
• Perform dissolution/precipitation/flux studies in biorelevant conditions.
• Support lab experiments in pharmaceutics and biopharmaceutics.

Skills

Formulation development

HPLC operation

Laboratory experiments

Data interpretation

Independent work

Team collaboration

ELN documentation

AI prompting

Project management

Education

MS in Chemistry

BS in Chemistry/Pharm Sci

Tools

HPLC systems

ELN software

Job description

Eurofins PSS seeks a highly motivated scientist to support the client's Early Formulation Science and Drug Delivery group on a client site in Cambridge, MA, with daily onsite presence five days a week.

This role will develop stage-appropriate traditional and enabled formulations for preclinical studies, conduct basic in vitro experiments and simple data interpretation to assess bio-performance and stability risks in small molecule drug candidates.